Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
This small cap pick has delivered an eye-popping early return

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Shares in eyewear frames designer-to-optically advanced spectacle lenses maker Inspecs (SPEC:AIM) are up the best part of 50% since we originally highlighted the group’s global growth potential and the scale benefits and synergies to come from the acquisition of eyewear supplier Eschenbach.
The Bath-based group’s reassuring first-quarter trading update (29 April) flagged a strong start to the year despite nationwide lockdowns in the UK, Germany and France and a variety of state lockdowns in the US.
The enlarged group delivered revenues of $67 million, which Peel Hunt estimates marked growth of 5% and leaves Inspecs on track to meet the broker’s $241 million sales forecast for 2021.
‘Whilst this performance marks a positive start to the year, the board remains cautious on 2021 as Covid-19 remains prevalent across the world,’ said Inspecs, also assuring the integration of Eschenbach is ‘progressing to plan and the benefits of the enlarged group working together are starting to be realised, with a number of joint projects underway’.
Peel Hunt estimates that pre-tax profit will rise from $3.6 million to $19.5 million in 2021, ahead of $24.9 million pre-tax profit and $256.5 million in sales for 2022.
SHARES SAYS: Inspecs is trading robustly and will benefit from market recovery and pent-up demand. Keep buying.
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.